San Francisco, CA, United States of America

Timothy C Matthews

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • San Francisco, CA (US) (2010)
  • Millbrae, CA (US) (2010)
  • San Mateo, CA (US) (2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy C Matthews

Introduction

Timothy C Matthews is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of Apo-2 ligand/TRAIL formulations. With a total of 4 patents to his name, Matthews continues to push the boundaries of innovation in his field.

Latest Patents

Matthews' latest patents focus on the purification and formulation of Apo-2 ligand/TRAIL. One of his key inventions involves the crystallization process for Apo2L/TRAIL purification. Additionally, he has developed formulations that include lyophilized and crystal forms of Apo-2L/TRAIL, which are stable and enhance trimer formation. These inventions also encompass methods for creating these formulations, along with devices and kits that utilize them.

Career Highlights

Timothy C Matthews is currently employed at Genentech, Inc., a leading biotechnology company. His work at Genentech has allowed him to collaborate with other talented professionals in the field, further advancing his research and innovations.

Collaborations

Some of his notable coworkers include Tanya P Lin and Zahra Shahrokh. Their collaborative efforts contribute to the ongoing success of their projects and the advancement of biotechnology.

Conclusion

Timothy C Matthews exemplifies the spirit of innovation in biotechnology through his patents and contributions to the field. His work continues to have a significant impact on the development of therapeutic formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…